Sinjard-L Tablet 10 mg+5 mg is a combination oral antidiabetic medication containing Empagliflozin and Linagliptin. This dual-action therapy is designed to provide effective glycemic control in adults with type 2 diabetes mellitus. By combining two different mechanisms of action, it helps lower blood glucose levels more efficiently than monotherapy. It is particularly beneficial for patients who require additional control despite using a single antidiabetic agent.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

• Empagliflozin 10 mg
• Linagliptin 5 mg

Mechanism of Action

Sinjard-L Tablet works through two complementary mechanisms:

• Empagliflozin: An SGLT2 inhibitor that reduces glucose reabsorption in the kidneys, leading to increased glucose excretion through urine.
• Linagliptin: A DPP-4 inhibitor that increases incretin hormone levels, enhancing insulin secretion and decreasing glucagon release in a glucose-dependent manner.

Together, these actions help maintain stable blood glucose levels throughout the day.

Indications

Sinjard-L Tablet is indicated for:

• Management of type 2 diabetes mellitus in adults
• Patients inadequately controlled on diet, exercise, or single-drug therapy
• Improving glycemic control with combination therapy

Dosage and Administration

• The usual recommended dose is one tablet once daily.
• Can be taken with or without food.
• Preferably taken at the same time each day for consistent results.
• Dosage adjustments should be made based on clinical response and physician recommendation.

Benefits

• Dual mechanism for enhanced blood glucose control
• Low risk of hypoglycemia when used alone
• Supports weight reduction through glucose excretion
• Convenient once-daily dosing
• Improves overall metabolic control

Side Effects

Common side effects may include:

• Urinary tract infections
• Nasopharyngitis
• Increased urination
• Headache
• Genital fungal infections

Rare but serious side effects include pancreatitis, ketoacidosis, or severe allergic reactions. Immediate medical attention is required if severe symptoms occur.

Precautions and Warnings

• Not recommended for type 1 diabetes or diabetic ketoacidosis.
• Use cautiously in patients with kidney or liver impairment.
• Monitor blood glucose and kidney function regularly.
• Maintain adequate hydration during treatment.
• Inform your doctor if you are pregnant or breastfeeding.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Drug Interactions

Sinjard-L Tablet may interact with:

• Other antidiabetic medications (risk of hypoglycemia)
• Diuretics (increased risk of dehydration)
• Strong CYP3A4 inducers or inhibitors

Consult your healthcare provider before using with other medications.

Storage

• Store below 30°C in a dry place
• Protect from light and moisture
• Keep out of reach of children.